Model Reliably Predicts Risk of Developing Psoriatic Arthritis Among Patients With Psoriasis
Investigators aimed to create and validate a risk prediction model for estimating the development of psoriatic arthritis among patients with psoriasis.
Diagnosis & Disease Information
High-Quality Evidence Lacking for Nondrug Treatments in Psoriatic Arthritis
Investigators assessed how the outcomes of patients with psoriatic arthritis may be improved using lifestyle modifications and nonpharmacologic and psychological interventions.
Use of Antipsoriatic Biologics Is Safe During Conception and Pregnancy
Investigators analyzed the effects of biologics on pregnancy outcomes in women with psoriasis.
JAK Inhibitors Associated With Higher Incidence of Malignancy vs TNF Inhibitors
Investigators assessed the association between JAK inhibitors and malignancy incidence, compared with placebo, methotrexate, and TNF inhibitors.
Targeted Therapies Do Not Increase Cardiovascular Risk in Psoriasis
Researchers sought to investigate the effect of targeted therapies on cardiovascular risk in psoriasis and psoriatic arthritis.
Depression, Anxiety Reduce Likelihood of Achieving Minimal Disease Activity in PsA
Researchers determined the effect of depression and anxiety on disease activity among patients with psoriatic arthritis.
Stelara Approved for Pediatric Psoriatic Arthritis
The approval is supported by evidence from adequate and well-controlled studies of Stelara.
FDA to Review Abrilada for Interchangeability With Humira
The PAS is supported by data from the REFLECTIONS B538-12 study, which assessed multiple switches between Abrilada and Humira, in addition to methotrexate, in adults with moderate to severe rheumatoid arthritis.
Is There a Link Between Psoriatic Arthritis and All-Cause Mortality?
In a population-based study, researchers examined the association between psoriatic arthritis and all-cause mortality and leading causes of death.
Does TNFi Therapy for Psoriatic Arthritis Affect COVID-19 Vaccine Immunogenicity?
Researchers studied the immune response to COVID-19 vaccination in patients with psoriatic arthritis receiving treatment with tumor necrosis factor inhibitors.
- Loading...
Loading...
Next post in Rheumatology
Loading... 
Loading...